Company Profile (AI Text)
Name: Sempresto
Canonical URL: https://wefunder.com/sempresto
Updated at: 2026-08-26T05:04:53Z

Tagline: The Always There autoinjector, on your phone

Key claims:
- Total raised on Wefunder: 512000 | citation: https://wefunder.com/sempresto#claim-total-raised
- Total investors: 48 | citation: https://wefunder.com/sempresto#claim-total-investors

Verified facts:
- Total raised on Wefunder: 512000 | observed_at: 2026-08-26T05:04:53Z | expires_at: 2026-08-27T05:04:53Z
- Total investors: 48 | observed_at: 2026-08-26T05:04:53Z | expires_at: 2026-08-27T05:04:53Z

Computed metrics:
- total_amount_raised: 512000
- total_investors: 48
- team_size: 6
- featured_investor_count: 4
- faq_count: 0
- recent_post_count: 1

Quick facts:
- Backed by $2.6M angel investment and Jefferson University Partnership | citation: https://wefunder.com/sempresto#claim-fact-1
- FDA filing targeted within 18 months, with no clinical trials required | citation: https://wefunder.com/sempresto#claim-fact-2
- Medtech leadership team trained at Harvard, MIT, Wharton, Johns Hopkins & UPenn Medicine | citation: https://wefunder.com/sempresto#claim-fact-3
- 15 patents granted, 10 pending across phone-based autoinjector technology (US & ex-US) | citation: https://wefunder.com/sempresto#claim-fact-4
- Targeting a $3B+ addressable market; 33M Americans living with food allergies | citation: https://wefunder.com/sempresto#claim-fact-5
- World-class team with 3 IPOs and 30+ commercial product launches | citation: https://wefunder.com/sempresto#claim-fact-6
- 85%+ projected gross margins at scale, priced below the current market average (not guaranteed) | citation: https://wefunder.com/sempresto#claim-fact-7
- Innovative autoinjector designed to attach to a smartphone, compatible with 95% of phones | citation: https://wefunder.com/sempresto#claim-fact-8

Recent posts:
- We built the autoinjector designed for how patients actually live (2026-08-25T17:36:04Z) https://wefunder.com/feed/374536